The Marshall Protocol was first developed by the biomedical researcher Trevor Marshall, Ph.D. It can be used treat chronic inflammatory and autoimmune conditions such as Lyme disease. This has been described as a ‘curative’ treatment that aims to tackle the root cause of the infection, rather than just cover up the symptoms.
Challenges Facing Sufferers
The problem with Lyme disease is that it can go undetected for a long period of time. This is because many of the symptoms are generalised and difficult to diagnose. This allows the Lyme bacteria (Borrelia burgdorferi) to spread throughout the body causing widespread infection. This bacteria has also been shown to ‘disguise’ itself and can hide in the body and evade drugs used to eradicated this form of infection. This means that chronic Lyme disease can be very resistant to standard treatments. This includes short term antibiotics which are commonly prescribed for Lyme disease and many sufferers experience months and even years of pain and discomfort whilst they try to overcome the condition
A New Approach to Treating Chronic Lyme Disease
The Marshall Protocol has been developed to tackle chronic, wide spread infections such as Lyme disease. Patients are given a type of medication known as olmesartan (also called Benicar), which boosts the immune system and increases the production of anti-microbial peptides. These peptides have been shown to be crucial in eradicating widespread pathogens and can tackle multi-infections at the same time. This is highly beneficial for Lyme disease sufferers as a large percentage have co-infections that can impede the healing process. Simultaneously to this treatment patients are also prescribed low-dose, pulsed antibiotics. This method of taking antibiotics is known to be much more effective at treating bacteria that can hide from standard treatments. These antibiotics work to weaken the bacteria by preventing them from producing the proteins they need to survive and also reproduce.
Once the bacteria start to die they release toxins into the bloodstream and this can result in a change in immunopathology, which is known as the ‘Herx’ reaction. This creates a number of symptoms in the body including a temporary hormonal imbalance and the stimulation of inflammatory cytokines. This means that the patient will see an escalation in the severity of symptoms for a few weeks or months, before their immune system can return to a more natural balance. Many patients find this increase in symptoms alarming, but the Herx reaction is very common and treatments can be adjusted to balance immunopathology. In severe cases of chronic Lyme disease it can take several years to complete the Marshall Protocol treatment. However patients will begin to see health improving gradually as the infection starts to lessen its hold on the body. In most cases a state of total remission can be achieved.
Can the Marshall Protocol Work For You?
One of the easiest ways to find out if the Marshall Protocol could be used to treat your condition is to get a blood test. This will identify whether you to have an elevated level of D metabolites, which is an indicator of chronic infection. A therapeutic probe should also be carried out which will monitor the patients during the stages of treatment to see whether any changes in immunopathology result from taking the Marshall Protocol medicines.







